Karyopharm to participate at the jefferies healthcare conference

Newton, mass. , june 1, 2022 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the company's senior management team will participate in a fireside chat at the jefferies healthcare conference on thursday, june 9, 2022 at 9:30 a.m.

KPTI Ratings Summary

KPTI Quant Ranking